Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“The key problem with early detection cancer screening studies isn’t the test or downstream procedures. It regards our inability to predict risk beyond age, and in the case of lung cancer how many cigarettes someone smoked.
This inability blows up the denominator blurring our ability to see its benefits for the individuals actually helps.”
Other articles featuring Drew Moghanaki on OncoDaily.